MeiraGTx Holdings (MGTX) Total Non-Current Liabilities (2017 - 2025)

MeiraGTx Holdings (MGTX) reported Total Non-Current Liabilities of $248.8 million for Q4 2025, up 24.97% on a YoY basis from $199.1 million in Q4 2024, and up 8.82% quarter-over-quarter from $228.7 million in Q3 2025.

MeiraGTx Holdings (MGTX) Total Non-Current Liabilities (2017 - 2025) Analysis & Trends

MeiraGTx Holdings has reported Total Non-Current Liabilities for 9 years, with the latest figure at $248.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities rose 24.97% year-over-year to $248.8 million; the trailing twelve-month figure through Dec 2025 stood at $248.8 million (up 24.97% YoY), and the FY2025 full-year result was $248.8 million, up 24.97% from the prior year.
  • Total Non-Current Liabilities for Q4 2025 stood at $248.8 million, up from $228.7 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $248.8 million in Q4 2025, with the low at $108.4 million in Q2 2022.
  • Historically, Total Non-Current Liabilities has averaged $173.0 million across 5 years, with a median of $184.7 million in 2023.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities fell 9.03% — and 2023, when it soared 70.16%.
  • MeiraGTx Holdings' Total Non-Current Liabilities stood at $132.7 million in 2021, then jumped by 49.47% to $198.3 million in 2022, then declined by 6.13% to $186.2 million in 2023, then climbed by 6.95% to $199.1 million in 2024, then climbed by 24.97% to $248.8 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $248.8 million (Q4 2025), $228.7 million (Q3 2025), and $194.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 MeiraGTx Holdings 910.47 Mn 844.54 Mn 74.89 Mn 248.82 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 248.82 Mn
Sep 30, 2025 228.66 Mn
Jun 30, 2025 194.30 Mn
Mar 31, 2025 189.57 Mn
Dec 31, 2024 199.10 Mn
Sep 30, 2024 200.87 Mn
Jun 30, 2024 184.12 Mn
Mar 31, 2024 185.06 Mn
Dec 31, 2023 186.17 Mn
Sep 30, 2023 172.99 Mn
Jun 30, 2023 184.44 Mn
Mar 31, 2023 195.68 Mn
Dec 31, 2022 198.32 Mn
Sep 30, 2022 176.66 Mn
Jun 30, 2022 108.39 Mn
Mar 31, 2022 124.30 Mn
Dec 31, 2021 132.68 Mn
Sep 30, 2021 113.58 Mn
Jun 30, 2021 119.15 Mn
Mar 31, 2021 117.03 Mn